Agenus to Report Third Quarter 2013 Financial Results on October 24, 2013;
Conference Call to Follow
LEXINGTON, Mass. -- October 16, 2013
Agenus Inc. (NASDAQ: AGEN) will release its third quarter 2013 financial
results before the market opens on October 24, 2013.
Agenus executives will host a conference call at 11:00 a.m. Eastern Time that
same day. To access the live call, dial 647-426-1845. The call will also be
webcast and will be accessible from the company’s website at
www.agenusbio.com/webcast/. A replay will be available approximately two hours
after the call through midnight Eastern Time on December 23, 2013. The replay
number is 416-915-1035, and the access code is 402191. The replay will also be
available on the company’s website approximately two hours after the live
Agenus Inc. is a biotechnology company working to develop treatments for
cancers and infectious diseases. The company is focused on immunotherapeutic
products based on strong platform technologies with multiple product
candidates advancing through the clinic, including several product candidates
that have advanced into late-stage clinical trials through corporate partners.
Between Agenus and its partners, 23 programs are in clinical development. For
more information, please visit www.agenusbio.com.
Media and Investor Contact:
Jonae R. Barnes, 617-818-2985
Investor Relations and
Press spacebar to pause and continue. Press esc to stop.